TYPE-1 INTERFERON AS AN ANTIINFLAMMATORY AGENT - INHIBITION OF LIPOPOLYSACCHARIDE-INDUCED INTERLEUKIN-1-BETA AND INDUCTION OF INTERLEUKIN-1 RECEPTOR ANTAGONIST

The effect of two type 1 interferons (r-metIFN-con1 and IFN-alpha(2b)) on the induction of specific cytokines and IL-1Ra in whole blood was examined. IFN-gamma was induced at low levels following treatment of diluted whole blood in some but not all subjects. IL-1Ra was induced by both r-metIFN-con1 and IFN-alpha(2b), but with 10- to 100-fold higher induction per ng IFN with r-metIFN-con1 than with IFN-alpha(2b). There was no detectable induction of TNF-alpha, IL-4, or IL-6 by either IFN. The effect of both IFN preparations was measured on LPS-induced inflammatory cytokines. Both IFN preparations inhibited the production of IL-1 beta when added to the diluted blood samples before LPS addition. However, neither IFN had any effect on IL-1 beta synthesis when added at the same time or after LPS induction. When added to total blood cells in the absence of LPS at low concentration (up to 100 pg/ml), IFN slightly stimulated IL-1 beta production, but at 1000 pg/ml or greater there was significant inhibition of IL-1 beta production. These results suggest that type I IFNs play a role in regulating the inflammatory response.